InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: DC15 post# 2864

Friday, 02/09/2024 9:58:21 AM

Friday, February 09, 2024 9:58:21 AM

Post# of 3017

With regard to communication and audience interpretation I felt that the answers provide more doubt that there will be an RSV phase III trial…

I did not get any vibes that anything has changed. The RSV programs will progress to phase-3, in the pediatric and/or adult populations, if the phase-2 data warrant advancing the programs. One analyst asked whether weak phase-2 data from the adult trial would preclude advancing the pediatric program, and the answer was no — each program stands on its own merits.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News